DrugPatentWatch Database Preview
Drugs in Development Information for TRV130
» See Plans and Pricing
What is the drug development status for TRV130?
TRV130 is an investigational drug.
There have been 10 clinical trials for TRV130.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Acute Pain and [disabled in preview]. The leading clinical trial sponsors are Trevena Inc., Kestrel Biologic, and Lotus Clinical Research, LLC.
There are seven US patents protecting this investigational drug and fifty international patents.
Summary for TRV130
| US Patents | 7 |
| International Patents | 50 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 46 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-06-01) |
| Vendors | 16 |
Recent Clinical Trials for TRV130
| Title | Sponsor | Phase |
|---|---|---|
| Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty | Trevena Inc. | Phase 3 |
| Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy | Trevena Inc. | Phase 3 |
| A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain | Trevena Inc. | Phase 3 |
Clinical Trial Summary for TRV130
Top disease conditions for TRV130
Top clinical trial sponsors for TRV130
US Patents for TRV130
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| TRV130 | Start Trial | Methods of treating hyperalgesia | TREVENA, INC. (King of Prussia, PA) | Start Trial |
| TRV130 | Start Trial | Opioid receptor ligands and methods of using and making same | TREVENA, INC. (King of Prussia, PA) | Start Trial |
| TRV130 | Start Trial | Opioid receptor ligands and methods of using and making same | Trevena, Inc. (King of Prussia, PA) | Start Trial |
| TRV130 | Start Trial | Opioid receptor ligands and methods of using and making same | Trevena, Inc. (King of Prussia, PA) | Start Trial |
| TRV130 | Start Trial | Opioid receptor ligands and methods of using and making same | Trevena, Inc. (King of Prussia, PA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for TRV130
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| TRV130 | Australia | AU2016372028 | 2035-12-14 | Start Trial |
| TRV130 | Canada | CA3007020 | 2035-12-14 | Start Trial |
| TRV130 | China | CN108366997 | 2035-12-14 | Start Trial |
| TRV130 | European Patent Office | EP3389657 | 2035-12-14 | Start Trial |
| TRV130 | Hong Kong | HK1251472 | 2035-12-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
